Orlistat: its current status as an anti-obesity drug
Author:
Publisher
Elsevier BV
Subject
Pharmacology
Reference36 articles.
1. Orlistat in the treatment of obesity;Ballinger;Expert Opin. Pharmacother.,2000
2. Role of lipase in the regulation of postprandial gastric acid secretion and emptying of fat in humans: a study with orlistat, a highly specific lipase inhibitor;Borovicka;Gut,2000
3. Weight control and risk factor reduction in obese subjects treated for 2 years with orlistat. A randomized controlled trial;Davidson;JAMA,1999
4. Drug treatment for obesity;Després;BMJ,2001
5. Treatment of obesity: need to focus on high risk abdominally obese patient;Després;BMJ,2001
Cited by 210 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Pancreatic lipase inhibitory and anti‐acne activity of Piper betle: Kinetic studies, in silico docking, and chemical characterization of bioactive compounds;Vietnam Journal of Chemistry;2024-07-22
2. Lemon basil seed-derived peptide: Hydrolysis, purification, and its role as a pancreatic lipase inhibitor that reduces adipogenesis by downregulating SREBP-1c and PPAR-γ in 3T3-L1 adipocytes;PLOS ONE;2024-05-22
3. Surgery is associated with better long-term outcomes than pharmacological treatment for obesity: a systematic review and meta-analysis;Scientific Reports;2024-04-25
4. Efficacy and safety of orlistat in male patients with overweight/obesity and hyperuricemia: results of a randomized, double-blind, placebo-controlled trial;Lipids in Health and Disease;2024-03-11
5. Synthesis and Characterization of Short α and β-Mixed Peptides with Excellent Anti-Lipase Activities;Molecules;2024-02-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3